F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
Based on clinical record review and staff interview, it was determined that the facility failed to ensure that
physician orders were followed and insulin administration was given timely for three of four residents
reviewed (Residents R2 R3, and Resident R4).
Residents Affected - Few
Findings Include:
Review of Resident R2's clinical record revealed diagnoses including but not limited to Diabetes Mellitus
(impaired ability of the body to produce or respond to insulin and thereby maintain proper levels of sugar
(glucose) in the blood).
Review of Resident R2's clinical record revealed a physician's order for Lantus (long acting insulin)
SoloStar Solution Pen-Injector 100 UNIT/ML (mililiter) with instruction to Inject 10 unit subcutaneously
(under the skin) one time a day for diabetic, give 8 am.
Review of Resident R2's clinical record including the September 2023 MAR (Medication Administration
Record) revealed the Lantus insulin was not administered within acceptable time parameter ten times from
September 1, 2023 through September 15, 2023.
Review of clinical record of Resident R3 revealed a diagnosis of Diabetes Mellitus.
Further review of Resident R3's clinical record revealed a physician's order initiated on April 21, 2023 for
NovoLOG FlexPen Solution Pen-injector 100 UNIT/ML (Insulin Aspart) with instructions to Inject 8 unit
subcutaneously four times a day for diabetic give 6a/12p/4p/8p.
Additional review of Resident R3's clinical record including September 2023 MARs revealed the following:
September 1, 2023 NovoLOG was to be administered at 4 p.m. but was not administered until 8:48 p.m.
with the next administration scheduled for 8 p.m. which was administered at 8:50 p.m. On September 2,
2023, Novolog was to be administered at 4 p.m. but was not administered until 7:41 pm. with the next
administration dose scheduled for 8 p.m. which was administered at 7:42 p.m. On september 3, 2023 the 4
p.m. scheduled dose was administered at 6:34 p.m. and the 8 p.m. NovoLOG dose was administered at
8:39 p.m. September 6, 2023 the NovoLOG 4 p.m. dose was administered at 6:35 p.m. and the 8 p.m. dose
was administered at 7:09 p.m.
Further review of Resident R3's September 2023 MARs revealed on September 12, 2023 the NovoLOG 6
a.m dose was not administered until 9:59 a.m. On September 13, 2023 the 4 p.m. Novolog dose was not
administered until 8:46 p.m. and the 8 p.m. dose was adminstered at 9:01 p.m.
Review of Resident R4's clinical record revealed a diagnosis of Diabetes Mellitus.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
395436
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395436
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/15/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Hickory House Nursing Home
3120 Horseshoe Pike
Honey Brook, PA 19344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Further review of Resident R4's clinical record revealed a physician's order for HumaLOG (short acting
insulin) KwikPen Subcutaneous Solution 100 UNIT/ML with instructions Inject as per sliding scale: if 0 - 200
= 0 units Call doctor if BGT (Blood Glucose Test) less than 70 and initiate hypoglycemia protocol; 201 - 250
= 2 units; 251 - 300 = 4 units; 301 - 350 = 6 units; 351 - 400 = 8 units call doctor if BGT over 400,
subcutaneously four times a day for diabetes give 7:30 am, 12p, 5p, 8p.
Residents Affected - Few
Review of Resident R4's clinical record including the September 2023 MAR revealed the HumaLOG insulin
was not administered within acceptable time parameters seven times from September 1, 2023 through
September 15, 2023.
Interview conducted on Sepember 15, 2023 at approximately 6:56 p.m. with the Nursing Home
Administrator when the above information was conveyed.
28 Pa Code 211.12(d)(1)(5) Nursing Services
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395436
If continuation sheet
Page 2 of 2